Using Alternating Tangential Flow in a 3000-L perfusion bioreactor, the company expects to reduce production time by up to 30% At its manufacturing site in Songdo, South Korea, Samsung BioLogics (SBL) ...
Repligen acquired Refine Technology and its Alternating Tangential Flow system for continuous bioprocessing. Repligen acquired the business of Refine Technology, including Refine's Alternating ...
Samsung BioLogics has implemented new perfusion technology that would reduce production time by up to 30 percent for its clients, the contract drug manufacturer said Monday. The company said it has ...
In recent years, fed-batch biomanufacturing has begun giving way to continuous manufacturing processes, as developers face pressure to balance affordability with high manufacturing quality. Although ...
Repligen Corporation has announced that it has completed an 11,000 square foot expansion of its U.S. manufacturing facility. The expansion includes a dedicated space for the production and assembly of ...
Upstream process intensification using perfusion cell culture has become a necessity for meeting today’s demand in monoclonal antibodies (mAbs) bioprocessing. By sustaining higher viable cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback